Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000454992 | SCV000540120 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 3% in African population, >1% in most other populations. In addition, no clearly associated clinical manifestations |
Labcorp Genetics |
RCV000004214 | SCV000631842 | benign | Proline dehydrogenase deficiency | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Institute for Genomic Medicine |
RCV000454992 | SCV000864289 | likely benign | not specified | 2017-04-18 | criteria provided, single submitter | clinical testing | BS1, BP6; This alteration has an allele frequency that is greater than expected for the associated disease, and was reported as a benign/likely benign alteration by a reputable source (ClinVar or other correspondence from a clinical testing laboratory). |
OMIM | RCV000004214 | SCV000024380 | pathogenic | Proline dehydrogenase deficiency | 2005-03-01 | no assertion criteria provided | literature only | |
OMIM | RCV000004215 | SCV000024381 | risk factor | Schizophrenia 4 | 2005-03-01 | no assertion criteria provided | literature only |